ES2179098T3 - Agente de prevencion o de tratamiento de la osteoporosis. - Google Patents
Agente de prevencion o de tratamiento de la osteoporosis.Info
- Publication number
- ES2179098T3 ES2179098T3 ES95910802T ES95910802T ES2179098T3 ES 2179098 T3 ES2179098 T3 ES 2179098T3 ES 95910802 T ES95910802 T ES 95910802T ES 95910802 T ES95910802 T ES 95910802T ES 2179098 T3 ES2179098 T3 ES 2179098T3
- Authority
- ES
- Spain
- Prior art keywords
- osteoporosis
- prevent
- treatment agent
- treat
- osteoporosis prevention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
MATERIAL PARA PREVENIR Y TRATAR LA OSTEOPOROSIS QUE SE CARACTERIZA POR CONTENER MINERALES Y OLIGOSACARIDOS INDIGERIBLES. ESTE MATERIAL PARA PREVENIR Y TRATAR LA OSTEOPOROSIS ES EXCELENTE PARA LA ABSORCION DEL CALCIO, REDUCIENDOSE LA CANTIDAD DE SAL OSEA QUE SE OBSERVA EN LA OSTEOPOROSIS. DE ACUERDO CON ESTO, LA UTILIZACION DEL MATERIAL PARA PREVENIR Y TRATAR LA OSTEOPOROSIS A QUE HACE REFERENCIA ESTE INVENTO, PERMITE PREVENIR Y RETRASAR LA EVOLUCION DE FORMA EFECTIVA DE LA OSTEOPOROSIS QUE AFECTA PARTICULARMENTE A LAS MUJERES POSTMENOPAUSICAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6068987A JPH07252156A (ja) | 1994-03-15 | 1994-03-15 | 骨粗鬆症予防治療材 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2179098T3 true ES2179098T3 (es) | 2003-01-16 |
Family
ID=13389532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95910802T Expired - Lifetime ES2179098T3 (es) | 1994-03-15 | 1995-03-13 | Agente de prevencion o de tratamiento de la osteoporosis. |
Country Status (7)
Country | Link |
---|---|
US (1) | US5900255A (es) |
EP (1) | EP0753302B1 (es) |
JP (1) | JPH07252156A (es) |
DE (1) | DE69527140T2 (es) |
ES (1) | ES2179098T3 (es) |
TW (1) | TW400232B (es) |
WO (1) | WO1995024909A1 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10108647A (ja) * | 1996-10-08 | 1998-04-28 | Meiji Seika Kaisha Ltd | 胃切除術後患者用ミネラル補給材 |
EP1060744B1 (en) * | 1998-03-06 | 2005-11-23 | Meiji Seika Kaisha, Ltd. | Preventives/remedies for osteoporosis |
US6241997B1 (en) | 1998-03-16 | 2001-06-05 | Smtm Group. Llc | Chewable calcium supplement and method |
GB9906009D0 (en) * | 1999-03-16 | 1999-05-12 | Nycomed Pharma As | Product |
US6436446B1 (en) * | 1999-07-30 | 2002-08-20 | Pharmavite Llc | Composition for increasing bone density |
US6846496B1 (en) | 1999-10-15 | 2005-01-25 | Orion Corporation | Treatment of osteoporosis |
EP1228764A1 (de) * | 2001-02-01 | 2002-08-07 | EnergyBalance AG | Calciumkomposition mit Oligofructose |
US6887897B2 (en) | 2001-07-31 | 2005-05-03 | Mission Pharmacal Company | Calcium glutarate supplement and phosphorus binder |
US8663679B2 (en) | 2004-04-29 | 2014-03-04 | Abbott Laboratories | Compositions for improving breast health in women |
US7435431B2 (en) * | 2004-07-28 | 2008-10-14 | Abbott Laboratories | Method for controlling body weight in estrogen-insufficient women |
US7601370B2 (en) * | 2004-07-28 | 2009-10-13 | Abbott Laboratories | Method for controlling body weight in estrogen-insufficient women |
US20060040001A1 (en) * | 2004-07-28 | 2006-02-23 | Johnson Catherine D | Nutritional compositions and methods for treating or preventing osteoporosis |
US20060029641A1 (en) * | 2004-08-05 | 2006-02-09 | Keller Nathan I | Calcium and magnesium nutritional supplement |
JP4588403B2 (ja) * | 2004-10-04 | 2010-12-01 | 森永乳業株式会社 | カルシウム・マグネシウム含有組成物の製造方法 |
JP2006111582A (ja) * | 2004-10-15 | 2006-04-27 | Suntory Ltd | カルシウム含有顆粒の製造方法 |
JP5001847B2 (ja) * | 2005-09-27 | 2012-08-15 | 旭化成ケミカルズ株式会社 | セロオリゴ糖含有組成物 |
JP5349744B2 (ja) | 2005-12-19 | 2013-11-20 | 松谷化学工業株式会社 | ミネラル吸収促進剤、食品及び飼料 |
JP5122766B2 (ja) | 2006-06-20 | 2013-01-16 | ユニチカ株式会社 | エコール産生促進組成物 |
JP5371415B2 (ja) * | 2008-12-24 | 2013-12-18 | 王子コーンスターチ株式会社 | 骨密度減少抑制組成物 |
EP3752168A4 (en) * | 2018-02-14 | 2021-10-13 | Profeat Biotechnology Co. Ltd. | USE OF FERROUS AMINO ACID CHELATE TO INCREASE CALCIUM ABSORPTION AND BONE MASS AND TREAT OSTEOPOROSIS |
JP6931231B2 (ja) * | 2018-02-28 | 2021-09-01 | ふるさと和漢堂株式会社 | イリコパウダーとフルクタンパウダーを含有させた栄養補助食品 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4689228A (en) * | 1985-08-26 | 1987-08-25 | University Patents, Inc. | Enhanced absorption of dietary mineral components |
US4867989A (en) * | 1986-09-09 | 1989-09-19 | Warner-Lambert Company | Chewing gum mineral supplement |
EP0346866A3 (en) * | 1988-06-16 | 1990-07-11 | Biochemie Gesellschaft M.B.H. | Composition for the prophylaxis of osteoporosis |
CA1337047C (en) * | 1988-08-18 | 1995-09-19 | Peter Dodd Cooper | Gamma inulin compositions |
JPH05238940A (ja) * | 1991-05-22 | 1993-09-17 | Pola Chem Ind Inc | 生体への吸収率の高い速効用薬剤及びその製造方法 |
JPH04349868A (ja) * | 1991-05-29 | 1992-12-04 | Asahi Chem Ind Co Ltd | ミネラル吸収促進剤 |
JPH04360664A (ja) * | 1991-06-04 | 1992-12-14 | Asahi Chem Ind Co Ltd | ミネラル吸収性促進剤 |
JPH0640922A (ja) * | 1991-07-19 | 1994-02-15 | Morinaga Milk Ind Co Ltd | カルシウム剤 |
JP2986133B2 (ja) * | 1991-07-29 | 1999-12-06 | ポーラ化成工業株式会社 | ミネラル吸収促進剤 |
JP2596509B2 (ja) * | 1992-12-11 | 1997-04-02 | 雪印乳業株式会社 | 新規なグルクロン酸含有オリゴ糖、その製造法及びその利用 |
JP3279695B2 (ja) * | 1993-01-08 | 2002-04-30 | 雪印乳業株式会社 | 分岐ガラクトオリゴ糖を有効成分とするミネラル吸収促進剤 |
JP3279694B2 (ja) * | 1993-01-08 | 2002-04-30 | 雪印乳業株式会社 | ラクチュロースオリゴ糖を有効成分とするミネラル吸収促進剤 |
JP3462535B2 (ja) * | 1993-08-31 | 2003-11-05 | サントリー株式会社 | ミネラル吸収促進組成物 |
US5431929A (en) * | 1994-07-28 | 1995-07-11 | Wm. Wrigley Jr. Company | Chewing gum products using oligofructose |
-
1994
- 1994-03-15 JP JP6068987A patent/JPH07252156A/ja active Pending
-
1995
- 1995-03-13 ES ES95910802T patent/ES2179098T3/es not_active Expired - Lifetime
- 1995-03-13 WO PCT/JP1995/000413 patent/WO1995024909A1/ja not_active Application Discontinuation
- 1995-03-13 EP EP95910802A patent/EP0753302B1/en not_active Revoked
- 1995-03-13 DE DE69527140T patent/DE69527140T2/de not_active Revoked
- 1995-03-15 TW TW084102458A patent/TW400232B/zh not_active IP Right Cessation
-
1997
- 1997-10-20 US US08/954,744 patent/US5900255A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0753302B1 (en) | 2002-06-19 |
EP0753302A4 (en) | 2000-02-16 |
EP0753302A1 (en) | 1997-01-15 |
US5900255A (en) | 1999-05-04 |
DE69527140T2 (de) | 2003-02-20 |
DE69527140D1 (de) | 2002-07-25 |
JPH07252156A (ja) | 1995-10-03 |
WO1995024909A1 (fr) | 1995-09-21 |
TW400232B (en) | 2000-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2179098T3 (es) | Agente de prevencion o de tratamiento de la osteoporosis. | |
BR9806118A (pt) | Processos para tratamento de pigmentação de pele | |
AR024874A1 (es) | Composiciones bactericidas | |
BR9706369A (pt) | Processo para tratamento de unhas humanas. | |
UY28213A1 (es) | Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos. | |
ES2146300T3 (es) | Utilizacion de composiciones antihelminticas para el tratamiento de infecciones causadas por anoplocephala perfoliata en equidos. | |
BR9916879A (pt) | Composição e método para tratamento do câncer utilizando óleos essenciais vegetais naturais | |
ES2113635T3 (es) | Aplicacion del riluzole en el tratamiento de lesiones neurologicas relacionadas con traumatismos. | |
MX151133A (es) | Mejoras en dispositivo de sujecion para el tratamiento de huesos fracturados | |
CO5060498A1 (es) | Composicion plaguicida sinergica que comprende emamectina (a) | |
ATE223213T1 (de) | Konjugierte linoleinsäure zur erhaltung oder erhöhung des knochenmineraliengehaltes | |
ID28949A (id) | Artikel-artikel penyerap yang menjaga atau memperbaiki kesehatan kulit | |
BR9809932A (pt) | Métodos para tratamento de distúrbios trombóticos | |
ATE305300T1 (de) | Verwendung von cyclopamine, zur behandlung des basalzellkarzinoms und anderer tumoren | |
AR005861A1 (es) | Una composicion liquida de limpieza de la piel ,y un metodo para potenciar el efecto antimicrobiano de formulaciones de limpieza de la piel | |
PL310475A1 (en) | Application of anticonvulsants in treating neuro-aids diseases | |
ES2178048T3 (es) | Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis. | |
BR0107667A (pt) | Composto de linezolida em forma de cristal que e farmaceuticamente útil como agente antibacteriano e método de preparação do mesmo | |
BR0010531A (pt) | Composições e usos de et743 para tratamento de câncer | |
PE20011280A1 (es) | Articulos que tienen un sistema de control de olor que comprende un polisacarido cationico y un agente de control de olor | |
PE30695A1 (es) | Composiciones orales | |
DE69825279D1 (de) | Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz | |
BR9810981A (pt) | Medicamento contendo ioimbina e arginina para tratamento de disfunção erétil | |
ES2178405T3 (es) | Uso de selegilina o de desmetilselegilina para tratar heridas, quemaduras y lesiones cutaneas. | |
ES2078904T3 (es) | Nuevos derivados de neplanocina. |